Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-24-002419

Chief Executive Officer acquired 7,179 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-26 Exercise or conversion : show line 1 in the form +7,179 $4.97 $35,680 7,179 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-26 Exercise or conversion : show line 2 in the form Options to purchase common stock −7,179 $4.97 $35,680 0 D
Loading xslF345X05/doc4.xml…